Susquehanna International Group, LLP Amneal Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $23,112 - $31,788	3,600 Added 8.33%	46,800 $389,000
Q2 2024 Aug 15, 2024	SELL	$5.36 - $7.11 $119,528 - $158,553	-22,300 Reduced 34.05%	43,200 $274,000
Q1 2024 May 07, 2024	BUY	$5.24 - $6.34 $343,220 - $415,270	65,500 New	65,500 $396,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $25,004 - $58,280	18,800 Added 131.47%	33,100 $102,000
Q1 2023 May 16, 2023	SELL	$1.27 - $2.7 $9,017 - $19,170	-7,100 Reduced 33.18%	14,300 $19,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $127,204 - $169,389	-64,900 Reduced 75.2%	21,400 $42,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $37,168 - $66,608	-18,400 Reduced 17.57%	86,300 $174,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.